These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1320649)

  • 1. Cell-mediated immunity to varicella-zoster virus.
    Arvin AM
    J Infect Dis; 1992 Aug; 166 Suppl 1():S35-41. PubMed ID: 1320649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine.
    Sharp M; Terada K; Wilson A; Nader S; Kinchington PE; Ruyechan WT; Hay J; Arvin AM
    J Infect Dis; 1992 May; 165(5):852-8. PubMed ID: 1314871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
    Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.
    Bergen RE; Diaz PS; Arvin AM
    J Infect Dis; 1990 Nov; 162(5):1049-54. PubMed ID: 2172393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus.
    Arvin AM; Sharp M; Moir M; Kinchington PR; Sadeghi-Zadeh M; Ruyechan WT; Hay J
    Viral Immunol; 2002; 15(3):507-16. PubMed ID: 12479399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
    Frey CR; Sharp MA; Min AS; Schmid DS; Loparev V; Arvin AM
    J Infect Dis; 2003 Jul; 188(1):40-52. PubMed ID: 12825169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
    Nader S; Bergen R; Sharp M; Arvin AM
    J Infect Dis; 1995 Jan; 171(1):13-7. PubMed ID: 7798653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA; Novelli VM; Keller PM; Ellis RW
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
    Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
    J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
    Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
    J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
    Jenkins DE; Yasukawa LL; Bergen R; Benike C; Engleman EG; Arvin AM
    J Immunol; 1999 Jan; 162(1):560-7. PubMed ID: 9886433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity.
    Sadzot-Delvaux C; Arvin AM; Rentier B
    J Infect Dis; 1998 Nov; 178 Suppl 1():S43-7. PubMed ID: 9852972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity.
    Watson B; Keller PM; Ellis RW; Starr SE
    J Infect Dis; 1990 Oct; 162(4):794-9. PubMed ID: 2169495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.